Market News & Trends

8/16/2011

Boehringer Ingelheim Licenses ProBioGen's GlymaxX Technology   Boehringer Ingelheim and ProBioGen AG recently announced they have signed a non-exclusive Licensing Agreement regarding ProBioGen's GlymaxX technology.…

8/9/2011

Celgene & Acceleron Enter Agreement Worth Up to $242 Million   Celgene Corporation and Acceleron Pharma, Inc. recently announced they have entered into a joint…

7/26/2011

Daiichi Sankyo Launches Direct Oral Factor Xa Inhibitor Daiichi Sankyo Company, Limited recently announced the launch of LIXIANA (JAN: Edoxaban Tosilate Hydrate, INN: edoxaban) in…